CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

By                    

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1570-1578

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v7-8 in Human Breast Cancer

By Tempfer C.   Losch A.   Heinzl H.   Hausler G.   Hanzal E.   Kolbl H.   Breitenecker G.   Kainz C.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2023-2025

Elsevier

Access to resources Recommend Favorite

Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer

By Vizoso Francisco   Fernández José   Corte María   Bongera Miguel   Gava Richard   Allende María   García-Muñiz José   García-Morán Manuel  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 11, 2004-11 ,pp. : 679-686

Springer Publishing Company

Access to resources Recommend Favorite

CD44v6: a target for antibody-based cancer therapy

By Heider Karl-Heinz   Kuthan Hartmut   Stehle Gerd   Munzert Gerd  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 567-579

Springer Publishing Company

Access to resources Recommend Favorite

Bladder Cancer Initiating Cells (BCICs) Are Among EMA-CD44v6+ Subset: Novel Methods for Isolating Undetermined Cancer Stem (Initiating) Cells

By Yang Y. M.   Chang J. W.  

Cancer Investigation, Vol. 26, Iss. 7, 2008-08 ,pp. : 725-733

Informa Healthcare

Access to resources Recommend Favorite